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Abstract
To study the effects of a standardized slow enteral feeding (SSEF) on the incidence of necrotizing enterocoltis (NEC), we compared outcomes for extremely low birth weight infants who followed a SSEF protocol (n = 125) to a similar group of historical controls (n = 294). There was no significant difference in the rate of NEC (5.6 vs. 11.2 %, p=0.10) between the SSEF and historical groups. However, the rate of NEC in infants with birth weight < 750g was significantly less in the SSEF group compared to controls (2.1 vs. 16.2%, p<0.01). The combined NEC/death was significantly less in the SSEF group (10.4 vs.19 .4%, p=0.03). However, in subgroup analysis, this effect was present only in infants with birth weight < 750g (12.8% vs. 29.5%, p=0.03). Compared to controls, feeding initiation day, days to full enteral feeding, parenteral nutrition days and the total central line days were all longer in the SSEF group. Compared to a historical feeding protocol, the use of a SSEF protocol was associated with significantly reduced incidence of NEC and combined NEC/death in infants with birth weight < 750g.
BACKGROUND
Necrotizing enterocolitis (NEC) continues to be a devastating neonatal illness especially in extremely low birth weight (ELBW, birth weight ≤ 1000g) preterm infants. 1, 2, 3 In very low birth weight (VLBW, birth weight < 1500g) infants, the mean incidence of NEC ranges from 7 to 9 % with an estimated case fatality rate of 15-30%
with the greatest mortality in infants requiring surgery for NEC. 1, 4, 5, 6, 7 In the most recently published NICHD research network outcome data, the incidence of NEC was 11% for preterm infants born at less than 28 weeks gestation. 8 In addition to short-term complications such as feeding intolerance, intestinal obstruction, and short-gut syndrome, surviving infants, particularly infants with surgical NEC, have poorer neurodevelopmental outcomes, and represent a huge financial burden to the health care system. 9 The pathophysiology of NEC is poorly understood, but it is likely a multifactorial disease. 7, 10 Immaturity of the intestinal tract, inappropriate responses to injury, abnormal bacterial colonization and genetic predisposition have all been implicated in the etiology of NEC. 7 Since little progress has been made in the management of NEC once it occurs, preventive strategies are more likely to have a greater impact in reducing the mortality and morbidity from NEC.
11
Most preterm infants who develop NEC have received enteral feeds. However, it remains unclear which aspects of feeding regimens affect the risk of NEC. Significant practice variation exists as to when feeds are initiated, how they are advanced, and how feeding intolerance is managed in preterm infants. 2 The modifiable risk factors related to enteral feeding for the development of NEC in preterm infants include the timing of introduction of feeds, the duration of trophic feeding and the rate of advancement of feeding and the type of milk human milk versus formula feeding. 12, 13 Standardizing the feeding regimen itself has been shown to reduce the incidence of NEC. 13 An immature enteric nervous system and intestinal dysmotility warrant gradual and cautious increments in enteral feedings. Observational studies have reported a higher incidence of NEC in centers where enteral feeding is introduced earlier and feeding volumes are advanced more quickly. 12, 13, 14, 15 Pietz et al reported a 0.4% incidence of NEC in 1158 VLBW infants (~ 60% were ELBW infants) who followed a late-onset, slow, continuous drip feeding protocol. 15 In contrast, a recent meta-analysis of 5 randomized controlled trials comparing slow advancement (< 15-20 ml/kg/day) versus faster advancement (30-35 ml/kg/day) did not detect any significant difference in NEC or allcause mortality. 16 However, ELBW infants were only included in two of the studies and both had broad exclusion criteria 17, 18 Due to the limited number of ELBW infants enrolled in these studies, caution must be used when generalizing these results to all ELBW infants, the group at highest risk for developing NEC. 16 The precise effect of enteral feeding advancement on occurrence of NEC has not yet been thoroughly investigated in ELBW infants. We hypothesized that exposure to a standardized slow enteral feeding (SSEF) protocol might reduce the incidence of NEC in ELBW infants without inducing significant adverse events. To investigate this hypothesis we carried out a prospective study in a cohort of ELBW infants who followed the SSEF protocol and compared the short-term outcomes with a historical control group of ELBW infants admitted to the same NICU prior to implementation of the SSEF protocol.
METHODS
The study took place in the Level III NICU at the MetroHealth Medical Center (MHMC). The NICU receives nearly 600 admissions per year including approximately 50
ELBW infants and serves a diverse underserved inner city population in Cleveland, Ohio.
The non-standardized feeding guideline for ELBW infants admitted to the MHMC NICU was replaced by the SSEF protocol in August, 2009 (see Table 1 for protocol description).
We stratified ELBW infants into 2 weight groups (< 750 g birth weight and 750-1000 g birth weight) and separate SSEF protocols were developed for each group. The SSEF protocols differed from previous feeding guidelines by delaying the start of enteral feeding, with more days to prime the intestine and more cautious increments in feeding. In addition, powdered human milk fortifier (HMF) was introduced earlier during the SSEF protocol when the enteral feed reached 100 ml/kg/day compared to 150 ml/kg/day with the previous guideline. At the attending physician's discretion, initiation of feeds was allowed to be delayed, if indicated, but no infant, was fed sooner than the designated times specified by the protocol. Feeding intolerance was defined as gastric residuals more than 2 ml for infants < 750 g birth weight and 3 ml for infants between 750-1000 g birth weight, or greater than 50% of the prior feeding, bile or blood-stained aspirates, abdominal distention/tenderness or presence of blood in the stool. Feeding intolerance was quantified by the number of days feeding were withheld ≥ 24 hours. 2.5g/kg/day half-way through the SSEF study period. Intravenous fat emulsion was discontinued when enteral feedings reached 100 ml/kg/day and PN was discontinued when enteral feedings reached 120 ml/kg/day. Human milk feeding was encouraged and, if not available, standard preterm formula (24 cal/oz) was used. Donor breast milk or probiotic preparations were not used during the study period.
The incidence of NEC in ELBW infants of ≤ 30 weeks of birth gestation admitted to the MHMC NICU between September, 2009 and December, 2012 who followed the SSEF protocol (SSEF group, prospective cohort), was compared to ELBW infants of ≤ 30 weeks of gestation admitted to the MHMC NICU between January, 2003 and July 2009, who followed a non-standardized feeding guideline (historical controls). We excluded infants with major anomalies/known gastrointestinal anomalies, operative diagnosis of spontaneous intestinal perforation, as well as infants who developed NEC/expired before initiation of feeds or were transferred to another facility before reaching full enteral feeding Trophic feeding volume 10 ml/kg/day 10 ml/kg/day 0.5 ml every 2 hours kcal/oz preterm formula every 2-3 hours.
Add human milk fortifier (HMF) when enteral
In both weight groups, change 2 hourly to 3 hourly feeds when infant weight > 1250g, then advance feeds feeds reach 150 ml/kg/day by 1m/feed/day until full feeds. Add HMF (1:50 ml) when enteral feeds reach 100 ml/kg/day and HMF (1:25 ml) at 150 ml/kg/day *SSEF-Slow standardized enteral feeding
The primary outcome of the study was the incidence of NEC in ELBW infants. We defined the occurrence of NEC as Bell Stage 2 or greater as per the modified Bell staging 19 or diagnosed at surgery. Secondary outcomes included the incidence of NEC or death combined, discharge weight, late-onset sepsis, cholestasis and metabolic bone disease of prematurity. We reviewed all medical records for infants' demographics [including gestational age (GA), birth weight (BW), small for gestational age (SGA), gender, race, mode of delivery, Apgar scores at 1 and 5 minutes, exposure to antenatal steroids and chorio-amnionitis and severity of illness measured by the Score of Neonatal Acute Physiology -Perinatal Extension (SNAP-PE)]. The SNAP-PE score is a 9-item neonatal illness severity and mortality risk score. 20 It is calculated from data collected on the day of admission to the NICU with points given for physiological items, birth weight, low Apgar score, and SGA. Nutritional data collected includes enteral feeding initiation day, trophic feeding days, trophic feeding volume, days to reach full enteral feeding 
STATISTICAL ANALYSIS
Based on the historic data, the incidence of NEC in ELBW infants was 11 % at the study initiation (MHMC NICU statistics). We determined that a prospective group sample size of 125 ELBW infants compared to 300 controls would have 80% power to detect a decrease in the incidence of NEC to 3.3 %, using a two-tailed 95% confidence level. This low value for the incidence of NEC was chosen based on the incidence of NEC observed in prior studies using a comparable late-onset slow enteral feeding. 15 We performed appropriate bivariate analysis to identify the unadjusted differences between the SSEF group and historical controls. All quantitative data are expressed as the mean ± standard deviation (SD), or median with interquartile range. A p value less than 0.05 was considered to be statistically significant. We also performed a propensity score (PS) analysis to calculate the adjusted SSEF group effect compared to controls on various outcomes. PS analysis represents an improvement over traditional modeling strategies. With PS methods, infants in the SSEF group are matched on a range of potentially confounding factors to infants in the control group. The two groups can then be considered equivalent to each other if no statistical difference exists between the groups on all the covariates included in the model. The two PS matched groups are then compared to each other on various outcomes, thus PS analysis represents a quasirandomized control design using observational data. Using a multiple logistic regression including baseline demographic and nutritional variables we calculated a PS for entering the SSEF group for each infant. Analysis using 1:1 greedy PS matching stratified by birth weight group as well as PS weighting by the inverse PS to calculate the average intervention effect were performed. Conditional logistic regression/paired t-test (PS matching) and survey design (PS weighting) was performed based on the PS matched/weighted pairs, as well as direct PS adjusted comparisons of the SSEF group to the controls on NEC and other secondary outcomes. Statistical software 'R' version R-2.14.1 was used for the statistical analysis of the data.
RESULTS
During the control study period, 391 ELBW infants were admitted to the MHMC NICU.A total of 97 infants met the exclusion criteria (72 infants died and 3 developed NEC before the initiation of enteral feeds, 3 infants were diagnosed with spontaneous intestinal perforation, 13 infants were  31 week birth gestation, 5 infants were transferred out before reaching full enteral feeds and 1 infant had a major congenital anomaly). During the SSEF study period, 145 ELBW infants were admitted to MHMC NICU and 20 of them met the exclusion criteria (17 infants died before the initiation of enteral feeds, 3 infants were  31 week birth gestation). The final study sample consisted of 294 infants in the control group and 125 infants in the SSEF group.
The demographics of the control and SSEF group patients are shown in Table 2 .
Overall there were no significant differences between the SSEF group and controls except there were more male infants in the SSEF group (Table 2) . (Table 3 ). The rate of human milk initiation was greater in the SSEF group, but in both groups the majority of infants were on formula when they reached full enteral feeds (Table 3 ).
The overall incidence of NEC (5.6 vs.11.2 %) and surgical NEC (1.6 vs. 4.8 %) were not significantly different between the SSEF group and controls (Table 4) The SSEF group required significantly more total central line days compared to controls (60.1 ± 29 vs. 34.4 ± 31, p <0.001) during their NICU stay ( Table 5 ). The incidence of culture-positive sepsis was not significantly different between the two groups, but infants in the SSEF group developed infection later in their NICU stay and were exposed to a longer duration of antibiotics (Table 5) . None of the SSEF group infants with NEC had concomitant sepsis compared to 33% in controls (p=0.16). The SSEF group had significantly higher peak ALP levels with no difference in incidence of cholestasis compared to controls ( Table 5 ). The SSEF group had less CLD, hypotension requiring inotropic medications, PDA ligation and ROP laser surgery compared to the controls (Table 5 ). In infants who survived to NICU discharge, the SSEF group, had significantly greater body weight (2981 ± 912 vs. 2694 ± 842) with similar length of NICU stay (110.2 ± 41 vs. 106.7 ± 43 days) ( Table 6 ). Extra-uterine growth restriction [EUGR, < 10 th percentile of weight for corrected gestational age (CGA)] was significantly less in the SSEF group compared to the controls, while infants with head circumference < 10 th percentile at NICU discharge was similar between the groups (Table 6 ). The SSEF group had significantly lower death (4.8 vs. 12.6 %, p= 0.02) and combined NEC/death (10.4 vs.
19.4 %, p=0.03) rates compared to controls (Table 6) variables were included in the multiple logistic regression model. The SSEF group had a mean propensity score of 0.36 ± 0.12, whereas the control group had a mean propensity score of 0.27 ± 0.15 (p < 0.001). In both the PS-matched groups (1:1 match of all SSEF group infants to the nearest PS matched controls without replacement) and the PSweighted groups, all the covariates included in the model were well balanced (none with p value < 0.05). The important PS-adjusted outcomes using various PS methods are summarized in Table 7 . compared to controls, while both of these outcomes were similar in the 750-1000g weight group. The PS-adjusted incidence of late-onset sepsis and cholestasis were similar between the groups, however peak ALP level was significantly higher in the SSEF group compared to the controls. In infants who survived to NICU discharge, the PSadjusted discharge weight and length of stay were similar between the SSEF group and controls.
Since there were significant differences in co-morbidities between the SSEF and control groups ( Table 5 ) that may be potentially associated with death, an additional logistic regression was performed to determine the adjusted SSEF group effect on the combined NEC/death outcome using all the covariates potentially related to combined NEC/death with a p value ≤ 0.10 in the unadjusted analysis (total antibiotics days, cholestasis, peak ALP, total central line days, chronic lung disease, inotropic use, PDA ligation, ROP laser). When controlling for these factors, being in the SSEF group was independently associated with significant reduction in combined NEC/death [OR 0.30
(CI: 0.12, 0.71), p<0.01]
DISCUSSION
Our study demonstrates that a standardized slow enteral feeding protocol with maternal human milk/preterm formula reduces the incidence of NEC and combined NEC/death in infants with birth weight < 750 g. These results are comparable to studies that used an exclusive human milk diet for reducing NEC. However, due to the prolonged nature of the SSEF protocol, these infants were exposed to longer central line and PN days. Despite taking longer to achieve full enteral feeding with the SSEF protocol, these infants demonstrated comparable weight gain at NICU discharge without prolonging their hospital stay.
Epidemiological studies have found that compared to non-Hispanic white infants, non-Hispanic African American infants have a higher incidence of NEC. 21 The incidence of NEC is also reported to be higher in male infants. 22 Holman et al described the trends and risk factors for infant mortality in the USA and showed that death from NEC was highest in VLBW infants who were black and male. 23 In addition, the SNAP-PE score in the range of 40-49 observed in our study population represents a high neonatal severity illness score with a predicted mortality rate of 15.9%. 20 Thus, the demographic characteristics of ELBW infants in our study (higher proportion of African American male infants) represent a group at particularly high risk for developing NEC.
Observational data suggests that delaying the introduction of enteral feeds until 5-10 days postnatally reduces the risk of NEC in VLBW infants. 12, 13, 15 However, prolonged NPO status may cause atrophy of the intestinal mucosa, delayed development of absorptive function, decreased motility and development of pro-inflammatory changes. 24 In various observational studies, infants who received early trophic feeds were reported to have better feeding tolerance, improved growth, reduced length of hospitalization and decreased likelihood of sepsis compared to infants who received delayed enteral feeds. 25, 26, 27 However, these potential short-term benefits of early enteral feeding were not shown to demonstrate a difference in preventing NEC. 16 A meta-analysis of 9 RCTs did not find a significant difference in NEC rate, time to regain birth weight, time to reach full enteral feeds, incidence of invasive infection, duration of hospital stay or all-cause mortality between early trophic feeding and enteral fasting (defined as NPO for 5-7 days). 16 The largest RCT that included ELBW infants randomized appropriately grown 26-30 weeks gestation infants into enteral fasting or trophic feeding for the first 14 days of life. 28 There was no difference in NEC rate (15.9% vs.
11.2%) and days to reach full enteral feeds (35 vs. 32) between trophic feeding and enteral fasting groups. 28 However, the primary outcome of the several included RCTs was not the incidence of NEC, but rather feeding intolerance or time to reach full enteral feeds. Additionally, only a minority of the participants in the included trials were ELBW infants. In our study, the average initial NPO period was only 3 days longer in the SSEF group compared to controls (13 vs. 10) and the days to reach full enteral feeds was significantly longer (63.6 ± 19.1 vs. 35.1 ± 19.3)( Table 3 ). This suggests that slow feeding advancement is the more likely associated with NEC reduction rather than the initial NPO period.
An immature enteric nervous system and intestinal dysmotility warrants gradual and cautious increments in enteral feedings. Aggressive enteral feeding advancement is a risk factor associated with NEC. 29, 30 However, a recent meta-analysis of 5 RCTs between slow advancement (< 15-20 ml/kg/day) versus faster advancement (30) (31) (32) (33) (34) (35) ml/kg/day) did not detect any significant difference in NEC or all-cause mortality. 16 Infants who had slower advancement took longer to regain birth weight (difference of 2-6 days) and to reach full enteral feeds (difference of 2-5 days). 16 However, ELBW infants were only included in two studies and both had broad exclusion criteria. 17, 18 One RCT that considered NEC as the primary outcome evaluated the effect of stable (20 ml/kg/day without advancement) versus advancing (20 ml/kg/day to goal 140 ml/kg/day) feeding volumes for a 10-day period in non-SGA VLBW infants. 30 Enteral feeds were initiated at an average age of 10 days as feeds were initiated only after removal of umbilical catheters and discontinuation of inotropic medications. Only onethird of the infants received human milk and the remainder were fed 24 cal/oz preterm formula. This study was prematurely terminated as they found a significantly higher incidence of NEC in infants fed advancing volumes compared with those fed with a minimal enteral feeding volume (10.4 vs. 1.4 %, 7p=0.03). 30 Since it is difficult to blind the caregivers to the group assignment, measurement bias may have overestimated the NEC rate in the advancing feed group. However, the large difference in NEC rate suggests that one should be cautious with aggressive feeding advancement in the early days of enteral feeding especially when using formula.
In a recently reported multicenter RCT, the incidence of NEC and surgical NEC in preterm infants with birth weight < 1250g, exclusively fed human milk feeding was 5.8% and 1.4%, compared to 15.9% and 10.1% in infants who were fed with human milk supplemented with bovine milk-based products (Sullivan, 2010) . 31 The infants included in this study were less at risk for NEC (21.6% African-American infants, 9.6% SGA infants, average birth weight 925 g) compared to our study (57.6% African-American infants, 25.6% SGA infants, average birth weight 766 g). The rates of feeding in the Sullivan study [up to 5 days of trophic feeding (10-20 ml/kg/day) followed by 10-20 ml/kg/day of feed advancement] was also 'slow' as per the definition set by Cochrane reviews (< 24 ml/kg/day feed advancement). 31 The days to full enteral feeding and days of PN (22 and 21) were significantly less compared to our study (63 and 62). Subgroup data (< 1000 g birth weight) from this study was not available to compare other outcomes such as like sepsis, cholestasis, central line days and hospital length of stay. With our SSEF protocol, we have achieved a similar rate of NEC to infants fed on an exclusively human milkbased diet. In Sullivan's study, even after following a standardized feeding regimen, the high rate of NEC (15.9%) in infants who received human milk supplemented with bovine milk-based products suggests that a much slower advancement of feeds such as in our SSEF protocol may be necessary to reduce NEC in infants receiving bovine milk-based formula or fortifiers.
Though no RCT has compared the effect of mother's own milk (MM) versus formula on NEC or death, there is widespread consensus about the short-and long-term benefits of MM in preterm infants including its protective effect on NEC. 32, 33 A recently reported quality improvement project in California to increase human milk use in VLBW infants resulted in a reduction of NEC from 7% to 2.4%. 34 In another prospective cohort study of VLBW infants, infants who received ≥ 50% enteral feeds as human milk within the first 14 days of life had one-sixth the odds of developing NEC compared to infants who received less than 50% enteral feeds with human milk (3.2 vs. 10.6%, OR =0.17, CI:
0.04 to 0.68, p=0.01). 35 The higher human milk initiation rate in the SSEF group compared to controls could be a potential confounder in our study, but this difference was balanced by PS methods and the outcomes were unchanged after PS analysis. If MM is not available, the AAP policy on breast feeding advocates donor breast milk (DBM) as a suitable alternative feeding. 33 A meta-analysis of studies comparing DBM and formula demonstrated that preterm infants fed with formula had more than twice the odds of NEC compared to infants fed with DBM. 36, 37 However, these studies included only a minority of extremely preterm infants and the effects of DBM combined with HMF were not evaluated. 31 A RCT that compared fortified pasteurized DBM and preterm formula, both used as supplements when MM was not available, did not find a protective effect of DBM on the combined incidence of late-onset sepsis and NEC. 32 Similarly in Sullivan's study, a high incidence of NEC (15.6%) was observed in infants who received human milk (MM or DBM) supplemented with bovine milk-based HMF. 31 The use of MM/DBM may help in the earlier initiation and attainment of full enteral feeding, but slowing the feeding advancement after supplementing with bovine milk HMF may help the immature intestine to adapt and reduce the risk for developing NEC. Dietdependent modification to the standardized feeding regimen may be needed for sustained prevention of NEC, e.g. -slower advancement of feeds in infants fed with bovine milk-based products alone or mixed with MM/DBM compared to an exclusive human milk diet.
In a population-based cohort study of ELBW infants, NEC occurred at an average postnatal age of 32 days 38 , similar to our controls. The nearly doubled time to the onset of NEC in the SSEF group suggests that delaying the establishment of enteral feeds also delays the onset of NEC. This is also consistent with the observation that NEC commonly occurs when feeding volume exceeds 100 ml/kg/day. 17, 30, 39 The need for surgical intervention is often used as a surrogate marker for the severity of NEC. 6, 7, 40 About 50% of infants < 750 g in our controls developed surgical NEC compared to none in the SSEF group (Table 4) . It is plausible that by using a SSEF protocol these extremely premature infants are more physiologically mature and have better protective mechanisms to tolerate the delayed onset of NEC leading to a lower risk of progressing to advanced NEC requiring surgical intervention.
Since conservative feeding strategies are associated with prolonged use of PN and central line days, they may alter other competing outcomes, especially the rate of nosocomial infections. There was no increase in the incidence of late-onset sepsis in the SSEF group compared to controls; however, the adoption of bundle strategies to prevent central line-associated bloodstream infections (CLABSI) potentially helped us to control the infection rate during the prospective study period. The statistically significantly higher peak serum alkaline phosphatase levels in the SSEF group (545 vs.
477 IU/dl in controls) reflect the potential nutrition-related harm associated with the SSEF protocol, however, the magnitude of difference may not be clinically meaningful.
We believe that the potential benefits of the SSEF protocol outweigh the risks as these infants had significant reduction in NEC/death and demonstrated comparable weight gain and head growth at NICU discharge without prolonging the NICU stay.
In the Sullivan study of infants' ≤ 1250g, the combined outcome of NEC/death was significantly less common in exclusively human milk fed infants compared to human milk supplemented with bovine milk-based product (7.3 vs. 20%). 31 With the SSEF protocol, we have demonstrated a similar reduction in NEC/death in ELBW infants (10.4 vs. 19.4%). This is even more significant as most of the reduction in NEC/death happened in infants with birth weight < 750g (12.8 vs. 29.5%) -the group with a reported NEC mortality rate of 40-60% as per the largest NEC study cohort published. 6 Based on our study results, the number of infants with birth weight < 750 g that would be needed to treat with the SSEF protocol to prevent one case of NEC is 7 and the number needed to treat to prevent one combined NEC/death is 6.
One of the strengths of our study is the use of NEC incidence as the primary outcome. Most of the previous single center studies were underpowered to detect a difference in NEC rate due to the relatively low incidence of NEC. However, our study is not without limitations. Only about one-third of the infants remained on human milk at full enteral feeds in spite of higher human milk initiation rate (80.2 %). Our results are not isolated as one study reported that only 30% of mothers were able to supply 100% of their extremely premature infants' needs. 32 This suggests that our outcomes are not generalizable to population fed mainly with human milk diet. Since our study spans more than a decade, it is possible that practice changes in the care of ELBW infants have affected the outcomes reported. For example, more medical treatment of PDA compared to primary PDA ligation and earlier extubation and aggressive non-invasive ventilation in the SSEF group reflects current neonatal practice. Also, we have reported only the short-term outcomes associated with the SSEF protocol as the study was not designed to assess the long-term neuro-developmental outcomes.
CONCLUSION
NEC is a devastating disease with high morbidity and mortality. Enteral feeding practices and the type of milk used represent two major modifiable risk factors of NEC in ELBW infants. Our study demonstrates that when using human milk or preterm formula, following a standardized slow enteral feeding protocol helps to reduce NEC and combined NEC/death in infants with birth weight < 750g. We believe the benefits of reducing the combined NEC/death rate outweighs the potential nutrition-related harm associated with delayed initiation and slower advancement of enteral feeds especially when using formula as initiation milk. However, because the etiology of NEC is multifactorial, only adequately powered, vigorously conducted randomized trials with
